Skip over main navigation
  • Log in
  • Basket: (0 items)
  • Perth Blood Institute
  • Thrombosis Australia
  • Thrombosis Australia Professionals
Perth Blood Institute
  • Search
  • Facebook
  • Linkedin
  • Email
  • Search
  • Facebook
  • Linkedin
  • Email
Login Register Subscribe Donate
Menu
  • About us
    • Vision, mission and values
    • What we do
    • Our facilities
    • Our team
      • Board
      • Investigators
    • Work with us
  • Clinical trials
    • Our clinical trials
    • Study experience
    • Start up processes
    • West Perth facilities
    • Ethics & governance
  • Current research projects
    • Current research projects
    • Research highlights
    • Research collaborations
      • PBI
      • APTIN
    • Participate in a research project
    • Published research
  • About blood disorders
    • Overview
    • Blood disorders
      • Anaemia
      • Antiphospholipid syndrome (APS)
      • Haemophilia
      • ITP
      • Polycythemia vera
      • Protein C and S deficiency
      • Sickle cell disease
      • Thrombocythaemia
      • Thrombophilia
      • TTP
      • von Willebrand Disease
    • Blood cancers
      • Chronic lymphocytic leukaemia
      • Leukaemia
      • Lymphoma
      • Multiple myeloma
      • Myelofibrosis (MF)
    • For patients and families
  • Stories
    • Living with a blood disorder
  • Get involved
    • Donate
    • Fundraise
    • Leave a gift in your will
    • Other ways to help
  • News and events
    • News and information
    • Significant days
      • 2024
      • 2023
      • 2022
    • Media
    • Publications
  • Admin
    • Log in
    • Perth Blood Institute
    • Thrombosis Australia
    • Thrombosis Australia Professionals
  • Basket: (0 items)
  • Chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia (CLL) is a blood cancer which affects the bone marrow and white blood cells. This type of cancer develops more slowly than other types of leukaemia and is the most prevalent subtype of leukaemia in Western countries, causing considerable health burden on patients.

Signs and symptoms

Commonly there are no symptoms in the early stages of the disease, however these are some which may develop as the cancer advances:

  • Enlarged painless lymph nodes.
  • Fatigue
  • Fever
  • Pain in upper left portion of the abdomen. This may be caused by an enlarged spleen.
  • Night sweats
  • Weight loss
  • Frequent infections

Cause

The specific cause of CLL is unknown, however it is suggested that mutations occur to the DNA of blood-producing cells. These mutations instruct the blood cells to produce abnormal, ineffective lymphocytes.

When there is an abundance of abnormal lymphocytes, they may crowd healthy lymphocytes and causing them to die. This can cause problems in the blood and organs of the body.

Risk factors

Some factors which may increase the risk of developing CLL include:

  • Age – commonly affects older adults.
  • Race – it is more likely to develop among white people.
  • Genetics – a family history of any type of blood or bone marrow cancers.
  • Chemicals – contact with certain herbicides and insecticides have been linked with an increased risk.

Statistics (Global Burden of Disease Study 1990-2019)

  • CLL accounts for 25-30% of all the leukaemia in Western countries.
  • Males are approximately two times likely to develop CLL than females. 

 

1990

2019

Incidence of cases

40,537

103,467

Global deaths

21,548

44,613

Disability-adjusted life years (DALY) cases

492,075

948,464


References

  • The global burden and attributable risk factors of CLL ... 2022.pdf
  • Chronic lymphocytic leukemia - Symptoms and causes - Mayo Clinic 

Published: 31st August, 2023

Updated: 7th December, 2023

Author: Gina Rodgers

Share this page
  • Email
  • Facebook
  • Twitter

Tag cloud

Acute Myeloid Leukaemia ADAMTS13 blood clots cancer contraceptive Follicular Lymphoma haemophilia A Microangiopathic Thrombocytopenia multiple myeloma oral contraceptive pregnancy Relapsed Multiple Myeloma small vessels thrombosis Thrombotic Thrombocytopaenic Pupura TMA

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Helpful links

  • Sitemap
  • Accessibility
  • Terms & conditions
  • Privacy policy
  • Contact us

Contact

18 Prowse Street
West Perth
WA 6005
P : +61 8 9200 5300
F : +61 8 9200 5324
E : [email protected]

  • Facebook
  • Instagram
  • Linkedin
  • Email

PBI is registered as an Income Tax Exempt Charity
CFN: CC21886
ACN: 164 941 815
ABN: 24 164 941 815

© Perth Blood Institute 2020